Evidence map›Paper›PMID 36718701›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2023

[Reinforced radiculoplasty for the treatment of symptomatic sacral Tarlov cysts: A clinical analysis of 71 cases].

C Wu, B Liu, J C Xie, Z Y Wang, C C Ma, J Yang, J J Sun, X D Chen, T Yu, G Z Lin and 7 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

C WuDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
B LiuDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
J C XieDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Z Y WangDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
C C MaDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
J YangDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
J J SunDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
X D ChenDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
T YuDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
G Z LinDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Y SiDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Y F HanDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
S H ChenDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
X L YinDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Q Q MaDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
M T ZhengDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
L ZengClinical Epidemiology Research Center, Peking University Third Hospital, Beijing 100191, China.
Peking University · CNPeking University Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the safety and efficacy of reinforced radiculoplasty in the treatment of symptomatic sacral Tarlov cysts (TCs).

methodsA retrospective analysis was performed on the clinical data and follow-up data of 71 patients with symptomatic sacral TCs who underwent reinforced radiculoplasty in the Neurosurgery Department of Peking University Third Hospital from June 2018 to March 2021. All the operations were performed under neuroelectrophysiological monitoring. Intraoperative cyst exploration, partial resection of the cyst wall, narrowing of the leak, nerve root sleeve radiculoplasty and artificial dural reinforcement were performed. The incidence of postoperative complications and new neurological dysfunction was analyzed. Visual analogue scale (VAS) was used to assess the changes of pain before and after surgery. The Japanese Orthopedics Association (JOA) low back pain score was used to evaluate the changes in nerve function before and after surgery.

resultsIn the study, 71 patients had 101 TCs, 19 (18.8%) TCs originated from the left S1 nerve, 26 (25.7%) originated from the left S2 nerve, 3 (3.0%) originated from the left S3 nerve, 14 (13.9%) originated from the right S1 nerve, 33 (32.7%) originated from the right S2 nerve, 6 (5.9%) originated from the right S3 nerve, all the TCs underwent reinforced radiculoplasty. Deep infection (1 case), subcutaneous effusion (1 case), fat li-quefaction (1 case) and urinary tract infection (4 cases) were recorded postoperatively. The patients were followed up for 12-43 months (median, 26 months). Two cases had new urinary retention after operation, and the catheter was removed at the end of the first and second months respectively. One case had new fecal weakness, which improved after 3 months. Compared with preoperation, VAS decreased significantly at the last follow-up [median, 6 (4-9)

conclusionFor patients with symptomatic sacral TCs, reinforced radiculoplasty can significantly improve the pain and nerve function, which is safe and reliable.

Indexed as

CystsTarlov CystsHumansNeoplasm Recurrence, LocalPainRetrospective StudiesPlastic surgery proceduresReinforced radiculoplastySacral canalTarlov cysts

Identifiers

PMID36718701
PMCPMC9894809
OpenAlexW4318668936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.